文献速递其他结缔组织病

LMCD1在实验性及硬皮病相关肺纤维化中促进肺肌成纤维细胞促纤维化特性的关键作用

Critical Role of LMCD1 in Promoting Profibrotic Characteristics of Lung Myofibroblasts in Experimental and Scleroderma-Associated Lung Fibrosis.
PubMed 文献 · Arthritis Rheumatol · 2023-01-25

本研究在系统性硬化症相关间质性肺病(SSc-ILD)患者肺组织和成纤维细胞及动物模型中探索LMCD1的作用。LMCD1在SSc-ILD患者肺组织和成纤维细胞中较对照持续升高,是TGFβ诱导I型胶原、纤连蛋白和α-SMA生成的关键因子,敲低LMCD1可降低细胞外基质蛋白表达、α-SMA转录活性与表达及成纤维细胞增殖和收缩活性。作者认为LMCD1可能是SSc-ILD的潜在新治疗靶点。

要点

  • LMCD1在SSc-ILD患者肺组织和成纤维细胞中较对照持续升高。
  • LMCD1是TGFβ诱导SSc-ILD肺成纤维细胞生成I型胶原、纤连蛋白和α-SMA的关键因子。
  • 作者认为LMCD1可能是SSc-ILD患者的潜在新治疗靶点。

核心结论

  • 本研究将LMCD1鉴定为一种促纤维化分子,参与SSc-ILD中肌成纤维细胞活化及持续纤维增殖。
  • 作者认为LMCD1可能是SSc-ILD患者的潜在新治疗靶点。

研究设计与样本

  • 研究在SSc-ILD患者与对照者的肺组织样本和成纤维细胞中,以及动物模型肺组织样本中,研究LMCD1的表达与作用。

主要发现

  • LMCD1在SSc-ILD患者肺组织样本及分离的成纤维细胞中较对照持续升高。
  • LMCD1在成纤维细胞特异性蛋白(FSP)驱动的组成性活化TGFβ受体I型(TGFβR1)转基因小鼠ILD模型和博来霉素诱导小鼠ILD模型的肺中高表达。
  • 在SSc-ILD患者肺成纤维细胞中,LMCD1是TGFβ诱导I型胶原、纤连蛋白和α-平滑肌肌动蛋白(α-SMA)生成的关键因子。
  • 用小干扰RNA敲低LMCD1可降低细胞外基质蛋白表达、降低α-SMA的转录活性与表达,并降低SSc-ILD肺成纤维细胞的增殖和收缩活性。
  • 在受累肺组织的致密纤维化区域,肺LMCD1与α-SMA共定位;在培养的硬皮病肺成纤维细胞中,LMCD1与血清反应因子共定位并相互作用,后者介导LMCD1诱导的肺成纤维细胞收缩活性。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Interstitial lung disease (ILD) is a serious complication and leading cause of mortality in patients with systemic sclerosis (SSc). In this study, we explored the role of LIM and cysteine-rich domains protein 1 (LMCD1) as a novel factor in the pathogenesis of SSc-related ILD (SSc-ILD). METHODS: The expression and effects of LMCD1 were studied in lung tissue samples and fibroblasts from SSc-ILD patients and control subjects as well as in lung tissue samples from animal models. RESULTS: LMCD1 was consistently elevated in lung tissue samples and in fibroblasts isolated from SSc-ILD patients as compared to controls. Additionally, LMCD1 was found to be highly expressed in the lung in the fibroblast-specific protein (FSP)-driven, constitutively active transforming growth factor β receptor type I (TGFβR1) transgenic mouse model of ILD and the bleomycin-induced mouse model of ILD. In lung fibroblasts from SSc-ILD patients, LMCD1 is an essential factor for the TGFβ-induced generation of type I collagen, fibronectin, and α-smooth muscle actin (α-SMA). Depletion of LMCD1 by small interfering RNA reduced the expression of extracellular matrix proteins and lowered transcriptional activity and expression of α-SMA, as well as decreased the proliferation and contractile activity of SSc-ILD lung fibroblasts. In dense fibrotic areas of affected lung tissue, lung LMCD1 colocalized with α-SMA. In cultured scleroderma lung fibroblasts, LMCD1 colocalized and interacted with serum response factor which mediates LMCD1-induced contractile activity of lung fibroblasts. CONCLUSION: Our study identifies LMCD1 as a profibrotic molecule contributing to the activation of myofibroblasts and the persistent fibroproliferation observed in SSc-ILD. Thus, LMCD1 may be a potential novel therapeutic target for patients with SSc-ILD.

来源:Arthritis Rheumatol,查看原文。版权归原作者所有。

引用

  1. Bogatkevich GS, Atanelishvili I, Bogatkevich AM, et al. Critical Role of LMCD1 in Promoting Profibrotic Characteristics of Lung Myofibroblasts in Experimental and Scleroderma-Associated Lung Fibrosis. Arthritis Rheumatol. 2023. PMID: 36103378. doi:10.1002/art.42344

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。